Strata Critical Medical (SRTA) Stock: Buy, Sell, or Hold?
SRTA - Strata Critical Medical, Inc. Class A Common Stock
$5.20
0.07 (1.27%)
▲
5d:
-3.26%
30d:
-13.85%
90d:
-5.37%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 04, 2026
0d
Get Alerted When SRTA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: SRTA shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: SRTA shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: SRTA is currently trading at $5.20, which is considered oversold relative to its 30-day fair value range of $5.41 to $6.08. From a valuation perspective, the stock is trading at a premium (Forward PE: 1574.2) compared to its historical average (62.4). At these levels, the market is pricing in 193.2% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, SRTA is showing sideways momentum. The price is currently testing key support at $5.10. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (27th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $9.56 (+84.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SRTA is showing sideways momentum. The price is currently testing key support at $5.10. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (27th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $9.56 (+84.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$5.41 -
$6.08
Company Quality Score
52/100
(HOLD)
Options IV Signal
27th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
79.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 27th percentile)
- NEUTRAL: Mixed technical signals (50/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 84.1% below Wall St target ($9.56)
- BEARISH: Market expects 193.2% growth - appears too optimistic based on history
- WARNING: Composite score 52/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$5.41 -
$6.08
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$0.60
(11.5%)
Support & Resistance Levels
Support Level
$5.10
Resistance Level
$6.15
Current Trend
Sideways
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
1574.24
Wall Street Target
$9.56
(+84.1%)
Revenue Growth (YoY)
60.7%
Profit Margin
15.7%
Valuation Premium vs History
+193.2% premium
PE vs Historical
1574.2 vs 62.4
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+193.2%
(market-implied from PE analysis)
1-Year Target
$7.79
(+50%)
2-Year Target
$11.69
(+125%)
3-Year Target
$17.53
(+238%)
3-Yr Target (if PE normalizes)
(PE: 1574→62)
PE COMPRESSION
$0.69
(-87%)
Significant PE compression expected
Share & Embed Analysis
Last updated: September 13, 2026 10:25 AM ET
Data refreshes hourly during market hours. Next update: 11:25 AM
Data refreshes hourly during market hours. Next update: 11:25 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SRTA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$285 | 61 BUY |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$451 | 50 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 55 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 52 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$135 | 56 HOLD |